Impetigo secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) No edit summary |
Usama Talib (talk | contribs) No edit summary |
||
| Line 9: | Line 9: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
| Line 18: | Line 15: | ||
[[Category:Infectious skin diseases]] | [[Category:Infectious skin diseases]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
{{WH}} | |||
{{WS}} | |||
Revision as of 13:46, 17 April 2017
|
Impetigo Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Impetigo secondary prevention On the Web |
|
American Roentgen Ray Society Images of Impetigo secondary prevention |
|
Risk calculators and risk factors for Impetigo secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]